« Back
Home /
Research Grade Sibrotuzumab

Research Grade Sibrotuzumab

Item no.	ANSY-DHG32201-1mg
Manufacturer	Antibody System
CASRN	216669-97-5
Amount	1 mg
Quantity options	100 ug 1 mg
Category	Oncology Metabolism Glucose Homeostasis Antibodies In Vivo Antibodies By Cell Type Carcinoma Melanoma Sarcoma
Clone	Sibrotuzumab
Specific against	Human (Homo sapiens)
Purity	>95% as determined by SDS-PAGE.
Alias	BIBH1,CAS: 216669-97-5
Available
Manufacturer - Type	Primary
Manufacturer - Applications	Research Grade Biosimilar
Manufacturer - Targets	Surface-expressed protease, Gelatine degradation protease FAP, Integral membrane serine protease, Dipeptidyl peptidase FAP, Seprase, FAP, Post-proline cleaving enzyme, APCE, SIMP, FAPalpha, 170 kDa melanoma membrane-bound gelatinase, Fibroblast activation protein alpha, Serine integral membrane protease, Prolyl endopeptidase FAP
Manufacturer - Host	Humanized
Storage Conditions	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Storage buffer	0.01M PBS, pH 7.4.
Purification	Protein A/G purified from cell culture supernatant.
Note	For research use only. Not suitable for clinical or therapeutic use.
Clonality	Monoclonal
Concentration	2.8mg/ml
Recombinant	Yes
Expression System	Mammalian Cells

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question